BridgeBio Oncology Therapeutics Price Chart
BridgeBio Oncology Therapeutics Volume Chart
BridgeBio Oncology Therapeutics Market Segments
Regular Trading Hours
-0.09(-0.95%)
| Open | $9.45 |
|---|---|
| Close | $9.36 |
| Low | $9.22 |
| Low Change | -0.23 (-2.43%) |
| High | $9.73 |
| High Change | +0.28 (+2.96%) |
| Range | $0.51 |
| Volume | 541.869K |
| Dollar Volume | $5.07M |
Premarket
-0.11(-1.14%)
| Open | $9.61 |
|---|---|
| Close | $9.50 |
| Low | $9.25 |
| Low Change | -0.36 (-3.75%) |
| High | $9.70 |
| High Change | +0.09 (+0.94%) |
| Range | $0.45 |
| Volume | 18.192K |
| Dollar Volume | $172.82K |
After Hours Yesterday
+0.34(+3.67%)
| Open | $9.26 |
|---|---|
| Close | $9.60 |
| Low | $9.26 |
| Low Change | 0.00 (0.00%) |
| High | $11.85 |
| High Change | +2.59 (+28.00%) |
| Range | $2.59 |
| Volume | 509.708K |
| Dollar Volume | $4.89M |
Regular Trading Hours Yesterday
-0.04(-0.43%)
| Open | $9.33 |
|---|---|
| Close | $9.29 |
| Low | $9.21 |
| Low Change | -0.12 (-1.29%) |
| High | $9.46 |
| High Change | +0.13 (+1.34%) |
| Range | $0.25 |
| Volume | 327.474K |
| Dollar Volume | $3.04M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $9.50 |
|---|---|
| Close | $9.50 |
| Low | $9.50 |
| Low Change | 0.00 (0.00%) |
| High | $9.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $950.00 |
BridgeBio Oncology Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $9.28 |
|---|---|
| 10 Day Moving Average (SMA10) | $8.97 |
| 20 Day Moving Average (SMA20) | $8.95 |
| 50 Day Moving Average (SMA50) | $9.65 |
| 100 Day Moving Average (SMA100) | $10.90 |
| 200 Day Moving Average (SMA200) | — |
BridgeBio Oncology Therapeutics Statistics
| Average Volume (30 Days) | 269.1K |
|---|---|
| P/E Ratio (Current) | -8.99 |
| EPS (Current) | -$1.04 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$114.50M |
| Cash Ratio | 10.66 |
| Current Ratio | 12.34 |
| Quick Ratio | 12.34 |
| Debt to Equity | 0.00 |
| Enterprise Value | $374.62M |
| EV to EBITDA | -3.92 |
| EV to Sales | 103945.59 |
| Price to Book | 1.82 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 207632.32 |
| Return on Assets | -0.19% |
| Return on Equity | -0.20% |
BridgeBio Oncology Therapeutics Stock Splits
There have been no stock splits for BridgeBio Oncology Therapeutics (BBOT).
BridgeBio Oncology Therapeutics Dividends
There have been no dividends for BridgeBio Oncology Therapeutics (BBOT).